Valuation Stratec SE Deutsche Boerse AG
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.30 EUR | +3.86% |
|
+6.01% | -18.74% |
| 05-12 | Stratec SE, Q1 2026 Earnings Call, May 11, 2026 | |
| 05-12 | STRATEC BIOMEDICAL SYSTEMS AG : Gets a Neutral rating from Deutsche Bank | ZD |
Company Valuation: Stratec SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,669 | 983.7 | 553.7 | 362.2 | 272.9 | 216.4 | - | - |
| Change | - | -41.06% | -43.71% | -34.58% | -24.66% | -20.71% | - | - |
| Enterprise Value (EV) 1 | 1,705 | 983.7 | 520.2 | 451.5 | 385.4 | 317 | 314.1 | 312.1 |
| Change | - | -42.32% | -47.12% | -13.2% | -14.65% | -17.75% | -0.91% | -0.64% |
| P/E Ratio | 42x | 33.8x | 42.6x | 22.6x | -1,123x | 17.3x | 11.8x | 10.4x |
| PBR | 8.12x | - | 2.37x | 1.49x | 1.15x | 0.89x | 0.86x | 0.82x |
| PEG | - | -1.3x | -0.8x | 1x | 11x | -0x | 0.3x | 0.8x |
| Capitalization / Revenue | 5.81x | 3.58x | 2.11x | 1.41x | 1.09x | 0.81x | 0.76x | 0.73x |
| EV / Revenue | 5.94x | 3.58x | 1.99x | 1.75x | 1.54x | 1.19x | 1.11x | 1.05x |
| EV / EBITDA | 25.6x | 16.8x | 12.5x | 9.17x | 9.48x | 7.56x | 6.52x | 5.99x |
| EV / EBIT | 31.4x | 21.8x | 19.2x | 13.5x | 15.3x | 12.6x | 10.2x | 8.75x |
| EV / FCF | 39.4x | - | 46.9x | 11.6x | -23.1x | 13.3x | 17.1x | 19.5x |
| FCF Yield | 2.54% | - | 2.13% | 8.6% | -4.32% | 7.52% | 5.86% | 5.13% |
| Dividend per Share 2 | 0.952 | - | 0.55 | 0.6 | 0.6 | 0.6708 | 0.7724 | 0.8587 |
| Rate of return | 0.69% | - | 1.21% | 2.01% | 2.67% | 3.77% | 4.34% | 4.82% |
| EPS 2 | 3.28 | 2.4 | 1.07 | 1.32 | -0.02 | 1.029 | 1.508 | 1.707 |
| Distribution rate | 29% | - | 51.4% | 45.5% | -3,000% | 65.2% | 51.2% | 50.3% |
| Net sales 1 | 287.3 | 274.6 | 261.9 | 257.6 | 250.9 | 267.1 | 283.9 | 297.5 |
| EBITDA 1 | 66.61 | 58.58 | 41.58 | 49.21 | 40.64 | 41.93 | 48.14 | 52.11 |
| EBIT 1 | 54.27 | 45.05 | 27.07 | 33.46 | 25.17 | 25.12 | 30.73 | 35.68 |
| Net income 1 | 39.96 | 29.22 | 13.07 | 16.02 | -0.242 | 14.02 | 18.29 | 20.05 |
| Net Debt 1 | 36.57 | - | -33.53 | 89.25 | 112.5 | 100.6 | 97.7 | 95.69 |
| Reference price 2 | 137.80 | 81.10 | 45.55 | 29.80 | 22.45 | 17.80 | 17.80 | 17.80 |
| Nbr of stocks (in thousands) | 12,111 | 12,130 | 12,156 | 12,156 | 12,156 | 12,156 | - | - |
| Announcement Date | 30/03/22 | 28/03/23 | 28/03/24 | 19/05/25 | 28/04/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.5x | 4.3x | 16.57x | 0.4% | 174B | |
| 45.14x | 11.83x | 26.47x | -.--% | 146B | |
| 28.75x | 5.22x | 16.43x | 0.8% | 127B | |
| 17.18x | 3.54x | 11.42x | -.--% | 69.72B | |
| 30.35x | 6.75x | 21.45x | -.--% | 49.01B | |
| 18.24x | 2.1x | 10.76x | 2.88% | 44.74B | |
| 25.22x | 5.03x | 17.33x | 0.79% | 36.67B | |
| 43.09x | 6.07x | 18.68x | -.--% | 34.91B | |
| 14.54x | 1.63x | 9.14x | 0.24% | 29.65B | |
| Average | 27.33x | 5.16x | 16.47x | 0.57% | 79.13B | |
| Weighted average by Cap. | 29.06x | 5.97x | 17.87x | 0.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SBS Stock
- SBS Stock
- Valuation Stratec SE
Select your edition
All financial news and data tailored to specific country editions
